Full Press Release Details
NEW BRUNSWICK, N.J. , Aug. 26, 2021 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ ) will participate in the Cantor Virtual Global Healthcare Conference on Tuesday, September 28 th . Mathai Mammen, Global Head, Research & Development Janssen Research Development and Scott White , Company Group Chairman NA Pharmaceuticals will represent the Company in a session scheduled at 10:00 a.m. (Eastern Time) .
This webcast will be available to investors and other interested parties by accessing the Johnson & Johnson website at www.investor.jnj.com .
A webcast replay will be available approximately 48-hrs after the live webcast.
SOURCE Johnson & Johnson